USA $15.14 Bn In-Vitro Diagnostics Market, 2022

DUBLIN, September 20, 2017 /PRNewswire/ --

The "USA In-Vitro Diagnostics Market - Growth, Trends & Forecast 2017 - 2022" report has been added to Research and Markets' offering.

The USA's market for In-Vitro Diagnostics is currently estimated to be worth USD 11.54 billion in the year 2014 and is expected to reach USD 15.14 billion by the end of 2020. The CAGR during this period of the forecast is 5.57%.

Currently, North America dominates the global market, with the market yet to reach saturation. The USA is the leading market both globally and in North America. Canada is the next big market in the North America region. This is due to the advances on the technology forefront and the higher GDP of the nation. This escalation is developing the need to analyze, review and forecast the growth of the In-Vitro Diagnostics market.

USA In-Vitro Diagnostics Market-Market Dynamics

The report details several factors driving and restraining the growth of the market. Some of these are discussed below.

Drivers

Some of the factors contributing to the growth of market are:

• Rapid increase in the chronic & infectious disease population
• Technological advances
• Rapidly aging population
• Advent of point of care diagnostics
• Restraints

Some of the factors limiting the growth of the market are a lack of proper reimbursement policies and stringent regulatory framework.

The report studies in detail the market for different In-Vitro Diagnostic techniques, which include clinical chemistry, hematology, immunoassays, point of care diagnostics, molecular diagnostics and coagulation. The products sector includes instruments, reagents, and data management systems. Molecular diagnostics currently dominate the global market and are expected to dominate it in the near future also.

Key Topics Covered:

1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology

2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities
3.5 Market Threats

4. Porter's Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants

5. Market Segmentation

6. Medical Devices Market - By Type
6.1 In - Vitro Diagnostics
6.1.1 By Technique
6.1.1.1 Clinical Chemistry
6.1.1.2 Immunoassays
6.1.1.3 Point of care diagnostics
6.1.1.4 Molecular Diagnostics
6.1.1.5 Hematology
6.1.1.6 Coagulation
6.1.1.7 Microbiology
6.1.2 By Type of product
6.1.2.1 Instruments
6.1.2.2 Reagents
6.1.2.3 Data Management Systems
6.1.3 By Usability
6.1.3.1 Disposable IVD Devices
6.1.3.2 Reusable IVD Devices
6.1.4 By Applications
6.1.4.1 Infectious diseases
6.1.4.2 Diabetes
6.1.4.3 Oncology
6.1.4.4 Cardiology
6.1.4.5 Auto Immune Diseases
6.1.4.6 Nephrology
6.1.4.7 Drug Testing
6.1.4.8 HIV/AIDS
6.1.4.9 Others
6.1.5 By End user
6.1.5.1 Laboratory
6.1.5.2 Academics
6.1.5.3 Hospitals
6.1.5.4 Point of Care testing
6.1.5.5 Others
6.1.6 By Geography
6.1.6.1 USA

7. Competitive Landscape
7.1 Mergers & Acquisitions
7.2 Agreements, Collaborations & Partnerships
7.3 New Product Launches
7.4 Recommendations to new market players

8. Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/jjbn9f/usa_invitro

Media Contact:

Laura Wood, Senior Manager
[e-mail]

For E.S.T Office Hours Call [phone]
For U.S./CAN Toll Free Call [phone]
For GMT Office Hours Call [phone]

U.S. Fax: [phone]
Fax (outside U.S.): [phone]